87 research outputs found

    Design of Mixing Station for Alternative Gaseous Fuels

    Get PDF
    Úkolem diplomové práce je navrhnout potrubní rozvod plynů do směšovací stanice a následně i navrhnout samotnou směšovací stanici. V textové části je nejprve vytvořena rešerše týkající se využívání technických a topných plynů v praxi. Na tuto část postupně navazují specifikace plynů, které se budou dopravovat do směšovací stanice. Ve výpočtové části se práce prostřednictvím výpočtových vztahů zabývá složením směsného plynu, fyzikálními vlastnostmi jednotlivých plynů i samotného plynu směsného, přičemž jsou vypočteny a navrženy potrubní tratě jednotlivých plynů směřujících do směšovací stanice. Konstrukční část práce se zabývá návrhem směšovací stanice a směšovací komory, ve které se jednotlivé plyny mísí. Grafická část práce obsahuje schémata jednotlivých potrubních tratí a směšovací stanice, 3D model směšovací komory a výkres směšovací komory.The task of the diploma thesis is to design the pipeline distribution of gases to the mixing station and then design the mixing station itself. In the text part is first created a search regarding the use of technical and heating gases in practice. This part is followed by the gas specifications that will be transported to the mixing station. In the computational part, the work with the help of calculation relations deals with the composition of the mixed gas, the physical properties of the individual gases and the mixing gas itself, and the pipelines of the individual gases leading to the mixing station are calculated and designed. The construction part deals with the design of the mixing station and the mixing chamber, in which the individual gases are mixed. The graphical part of the thesis contains diagrams of individual pipeline lines and mixing stations, a 3D model of the mixing chamber and a drawing of the mixing chamber.361 - Katedra energetikyvýborn

    Targeting AKT with costunolide suppresses the growth of colorectal cancer cells and induces apoptosis in vitro and in vivo

    Get PDF
    BACKGROUND: Colorectal cancer (CRC) is a clinically challenging malignant tumor worldwide. As a natural product and sesquiterpene lactone, Costunolide (CTD) has been reported to possess anticancer activities. However, the regulation mechanism and precise target of this substance remain undiscovered in CRC. In this study, we found that CTD inhibited CRC cell proliferation in vitro and in vivo by targeting AKT. METHODS: Effects of CTD on colon cancer cell growth in vitro were evaluated in cell proliferation assays, migration and invasion, propidium iodide, and annexin V-staining analyses. Targets of CTD were identified utilizing phosphoprotein-specific antibody array; Costunolide-sepharose conjugated bead pull-down analysis and knockdown techniques. We investigated the underlying mechanisms of CTD by ubiquitination, immunofluorescence staining, and western blot assays. Cell-derived tumour xenografts (CDX) in nude mice and immunohistochemistry were used to assess anti-tumour effects of CTD in vivo. RESULTS: CTD suppressed the proliferation, anchorage-independent colony growth and epithelial-mesenchymal transformation (EMT) of CRC cells including HCT-15, HCT-116 and DLD1. Besides, the CTD also triggered cell apoptosis and cell cycle arrest at the G2/M phase. The CTD activates and induces p53 stability by inhibiting MDM2 ubiquitination via the suppression of AKT's phosphorylation in vitro. The CTD suppresses cell growth in a p53-independent fashion manner; p53 activation may contribute to the anticancer activity of CTD via target AKT. Finally, the CTD decreased the volume of CDX tumors without of the body weight loss and reduced the expression of AKT-MDM2-p53 signaling pathway in xenograft tumors. CONCLUSIONS: Our project has uncovered the mechanism underlying the biological activity of CTD in colon cancer and confirmed the AKT is a directly target of CTD. All of which These results revealed that CTD might be a new AKT inhibitor in colon cancer treatment, and CTD is worthy of further exploration in preclinical and clinical trials.1

    Behavior Evaluation for Reinforced Concrete Columns with Rectangular Hollow Section Subjected to Axial Compression and Biaxial Bending

    No full text
    In order to evaluate the behavior of reinforced concrete columns with rectangular hollow section subjected to axial compression and biaxial bending, the calculation formula of load capacity and moment-curvature relationship are derived according to the distribution type of neutral axis in this paper. The load capacity and rotation ductility of the bottom control section of three reinforced concrete specimen bridge columns with rectangular hollow section under different axial compression ratio, reinforcement ratio and stirrup ratio are analyzed based on these calculation formulae. The Mx–My interaction curves and moment-curvature curves of bridge column specimens derived from the theoretical calculation show good agreement with the experimental data obtained by cyclic testing of three specimens under axial compression and biaxial bending. The results show that the P–Mx–My interaction has considerable effects on the behavior of the reinforced concrete bridge columns with rectangular hollow section. If these interaction effects are ignored, then the load capacity and deformation are overestimated and this fact can be crucial from the viewpoint of design

    Evaluation of a Current Vehicle Load Model Using Weigh-in-Motion Records: A Case in China

    No full text
    In order to assess the vehicle load carrying capacity of existing bridges on the national highway G103 in Beijing, the vehicle load model for the practical traffic flow conditions needs to be determined. Based on the traffic axle load data measured by the weigh-in-motion system and the methods proposed by General Code for Design of Highway Bridges and Culverts (JTG D60-2004) and Code for Design of Highway Reinforced Concrete and Prestressed Concrete Bridges and Culverts (JTG D62-2004), the vehicle load parameters under practical traffic flow conditions are investigated. A typical 6-axle vehicle model with a 2-1-3 axial pattern is proposed by using the statistical analysis of total weight, axial weight, etc. The live load effects of Daliushu No. 2 Bridge, one highway bridge on the national highway G103, are analyzed using the proposed model and compared to the vehicle load model given in the Chinese code. The results show that there are great differences in the vehicle load parameters and the live load effects from the proposed vehicle load model increased by 20–50% compared with the model given by the code. The overweight vehicles are potential threats to the safety of existing bridges

    PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential

    No full text
    T-lymphokine-activated killer cell-originated protein kinase (TOPK, also known as PDZ-binding kinase or PBK) plays a crucial role in cell cycle regulation and mitotic progression. Abnormal overexpression or activation of TOPK has been observed in many cancers, including colorectal cancer, triple-negative breast cancer, and melanoma, and it is associated with increased development, dissemination, and poor clinical outcomes and prognosis in cancer. Moreover, TOPK phosphorylates p38, JNK, ERK, and AKT, which are involved in many cellular functions, and participates in the activation of multiple signaling pathways related to MAPK, PI3K/PTEN/AKT, and NOTCH1; thus, the direct or indirect interactions of TOPK make it a highly attractive yet elusive target for cancer therapy. Small molecule inhibitors targeting TOPK have shown great therapeutic potential in the treatment of cancer both in vitro and in vivo, even in combination with chemotherapy or radiotherapy. Therefore, targeting TOPK could be an important approach for cancer prevention and therapy. Thus, the purpose of the present review was to consider and analyze the role of TOPK as a drug target in cancer therapy and describe the recent findings related to its role in tumor development. Moreover, this review provides an overview of the current progress in the discovery and development of TOPK inhibitors, considering future clinical applications
    corecore